Literature DB >> 15069001

Montelukast-induced hepatitis.

Marc F Goldstein, James Anoia, Martin Black.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15069001     DOI： 10.7326/0003-4819-140-7-200404060-00042

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

Review 1.  Important elements for the diagnosis of drug-induced liver injury.

Authors:  Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-17       Impact factor: 11.382

2.  Is montelukast effective and well tolerated in the management of asthma in young children?: Part A: Evidence-based answer and summary.

Authors:  Gary M Doherty
Journal:  Paediatr Child Health       Date:  2007-04       Impact factor: 2.253

3.  Hepatotoxicity caused by montelukast in a paediatric patient.

Authors:  Dariusz M Lebensztejn; Anna Bobrus-Chociej; Monika Kłusek; Miroslawa Uscinowicz; Joanna Lotowska; Maria Sobaniec-Lotowska; Maciej Kaczmarski
Journal:  Prz Gastroenterol       Date:  2014-05-05

4.  Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2019-10-25       Impact factor: 5.810

5.  Probable montelukast-induced hepatotoxicity in a pediatric patient: case report.

Authors:  Faruk Incecik; Yusuf Onlen; Ozlem Sangun; Sabahat Akoglu
Journal:  Ann Saudi Med       Date:  2007 Nov-Dec       Impact factor: 1.526
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.